Tuesday, May 7, 2024
Advertisement

Re:Cognition Health continues UK expansion

Re:Cognition Health has announced plans to open a new clinic in Bristol in May. The Alzheimer’s research and cognitive health provider said the 3,500sqft facility...

OCL Vision opens first site outside London

Eye surgery specialist OCL Vision has opened a second centre in Elstree, Hertfordshire. The company, which opened its flagship site in London’s Harley Street Medical...

Benenden partners with nursing provider RedArc

Benenden Health has partnered with nursing provider RedArc to offer members who have been diagnosed with cancer one-to-one nursing support. The healthcare mutual society said the move follows...

Elysium leadership praised but more work needed to embed improvements, says CQC

Elysium Healthcare has been praised by the CQC for establishing good continuity of services and driving improvements in the care it provides. However, the...

Independent providers donate medical supplies to Ukraine

The UK’s independent healthcare providers have now donated over one million medical supplies to support the effort in Ukraine.   Working in partnership with the...

Taskforce will develop proposals to maximise use of independent sector capacity

The independent sector is set to play a bigger role in reducing NHS waits under plans to accelerate elective recovery announced by Health Minister...

Cygnet reports explosion in demand for CAMHS services in wake of pandemic

Mental health provider Cygnet Health Care has released figures showing a sharp increase in demand for its Child and Adolescent Mental Health (CAMHS) facilities...

Cost of living crisis beginning to impact self-pay demand, says Broadstone

Growth in demand for self-pay could be beginning to slow as the cost of living crisis impacts patients’ ability to fund their treatment, according...

Active Care Group urged to row back on staff relocation plans

Active Care Group (ACG) has been urged by trade union officials to row back on plans to relocate staff following its decision to close...

MHRA approves London-based psychedelic drug trial

The Medicines and Healthcare products Regulatory Authority has approved a new clinical trial to test whether psychedelic drugs can treat major depressive disorder. A novel...